Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$5.71 - $8.85 $212,434 - $329,255
-37,204 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$6.93 - $10.07 $13,520 - $19,646
-1,951 Reduced 4.98%
37,204 $272,000
Q4 2020

Feb 16, 2021

BUY
$6.65 - $8.83 $6,556 - $8,706
986 Added 2.58%
39,155 $318,000
Q2 2020

Aug 14, 2020

BUY
$3.5 - $6.09 $133,591 - $232,449
38,169 New
38,169 $208,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $375M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.